iCo Therapeutics iCo Therapeutics Inc.

  • Home
  • Corporate Overview
    • Overview
    • Corporate Video
    • Partnering Strategy
    • Management Team
    • Board of Directors
    • Strategic Advisory Board
    • Professional Advisors
  • Pipeline
    • iCo-007
    • Antisense Technology
    • iCo-008
    • iCo-009
    • Clinical Trials
  • Investor Relations
    • Overview
    • Press Releases
    • Media Coverage
    • Upcoming Events
  • Careers
    • About Vancouver
    • Current Opportunities
  • Contact Us

Investor Relations

iCo has been selected as one of Canada’s 2008 Top 10™ Competition winners. Top 10™ winners are chosen by an independent expert panel of Canadian and U.S. venture capitalists.

Media Coverage

image iCo in Business in Vancouver April 2009.pdf

image iCo in Business in Vancouver February 2009.pdf

image iCo-009 in The Scientist Feb 09.pdf

image iCo in Business in Vancouver December 2008.pdf

image iCo-009 in Leashing Leishmaniasis.pdf

image iCo in UBC Alumni Magazine 2007.pdf

image iCo Therapeutics Announces Licensing Deal

image Antisense Technology

image Pace of iCo Unmatched by Biotech Competitors

image The Wall Street Transcript – March 20, 2006

image Wanted – Buck for Canadian Biotech

image Retina Today – Fall 2006

image

Investor & Media Contact

John Meekison
Chief Financial Officer
604.602.9414

.(JavaScript must be enabled to view this email address)

Contact Us

Items with an asterisk * are required







What season comes after autumn?

  • Home
  • Corporate Overview
  • Pipeline
  • Investor Relations
  • Careers
  • Contact Us

Copyright © 2005 iCo Therapeutics Inc. All rights reserved. Terms of Use.